BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 905 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,761,828 | -35.3% | 82,563 | -17.3% | 0.01% | -36.4% |
Q1 2024 | $4,268,340 | +335.2% | 99,830 | +293.6% | 0.01% | +266.7% |
Q4 2023 | $980,764 | +167.7% | 25,362 | +161.4% | 0.00% | +50.0% |
Q3 2023 | $366,354 | -77.9% | 9,703 | -73.3% | 0.00% | -66.7% |
Q2 2023 | $1,655,990 | +37.4% | 36,332 | +22.7% | 0.01% | +100.0% |
Q1 2023 | $1,205,191 | -7.6% | 29,621 | +15.7% | 0.00% | -62.5% |
Q4 2022 | $1,304,717 | +5.2% | 25,595 | +11.2% | 0.01% | -46.7% |
Q3 2022 | $1,240,000 | -13.5% | 23,015 | +3.2% | 0.02% | -6.2% |
Q2 2022 | $1,434,000 | +10.4% | 22,304 | +33.3% | 0.02% | -20.0% |
Q1 2022 | $1,299,000 | -21.3% | 16,734 | -13.0% | 0.02% | -20.0% |
Q4 2021 | $1,651,000 | +56.3% | 19,227 | +46.4% | 0.02% | +8.7% |
Q3 2021 | $1,056,000 | -9.4% | 13,131 | -9.2% | 0.02% | -8.0% |
Q2 2021 | $1,165,000 | -11.8% | 14,469 | -7.6% | 0.02% | -19.4% |
Q1 2021 | $1,321,000 | -10.3% | 15,665 | -14.7% | 0.03% | -34.0% |
Q4 2020 | $1,473,000 | +8.6% | 18,354 | +8.8% | 0.05% | -16.1% |
Q3 2020 | $1,356,000 | +27.2% | 16,863 | +36.1% | 0.06% | -5.1% |
Q2 2020 | $1,066,000 | +14.7% | 12,388 | +8.2% | 0.06% | +1.7% |
Q1 2020 | $929,000 | -31.2% | 11,445 | -29.1% | 0.06% | -15.9% |
Q4 2019 | $1,350,000 | -10.5% | 16,138 | -6.4% | 0.07% | -22.5% |
Q3 2019 | $1,509,000 | +75.9% | 17,246 | +64.6% | 0.09% | +64.8% |
Q2 2019 | $858,000 | -1.9% | 10,480 | -2.6% | 0.05% | -8.5% |
Q1 2019 | $875,000 | -25.5% | 10,758 | -39.7% | 0.06% | -25.3% |
Q4 2018 | $1,174,000 | -14.9% | 17,837 | -0.3% | 0.08% | -17.7% |
Q3 2018 | $1,379,000 | -19.2% | 17,891 | -22.6% | 0.10% | -23.8% |
Q2 2018 | $1,706,000 | +45.4% | 23,110 | +28.1% | 0.13% | +40.0% |
Q1 2018 | $1,173,000 | -16.7% | 18,042 | -17.2% | 0.09% | -5.3% |
Q4 2017 | $1,409,000 | -29.6% | 21,798 | -31.6% | 0.10% | -33.1% |
Q3 2017 | $2,001,000 | +619.8% | 31,885 | +556.1% | 0.14% | +517.4% |
Q2 2017 | $278,000 | -73.6% | 4,860 | -76.1% | 0.02% | -73.9% |
Q1 2017 | $1,053,000 | – | 20,296 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |